Danaher Corporation $DHR Stock Acquired by Focus Financial Network Inc.

Focus Financial Network Inc. increased its position in Danaher Corporation (NYSE:DHR) by 163.1% during the third quarter, HoldingsChannel reports. The institutional investor owned 26,939 shares of the conglomerate’s stock after acquiring an additional 16,699 shares during the period. Focus Financial Network Inc.’s holdings in Danaher were worth $5,968,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Main Street Group LTD acquired a new stake in Danaher in the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC bought a new stake in shares of Danaher during the 2nd quarter worth $25,000. Marquette Asset Management LLC grew its stake in Danaher by 192.1% in the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after buying an additional 73 shares during the last quarter. Evolution Wealth Management Inc. grew its stake in Danaher by 208.0% in the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock valued at $29,000 after buying an additional 104 shares during the last quarter. Finally, Field & Main Bank acquired a new position in Danaher in the 2nd quarter valued at $29,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $223.30 on Wednesday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company’s 50-day simple moving average is $212.41 and its 200 day simple moving average is $195.13. The stock has a market cap of $156.98 billion, a P/E ratio of 39.66, a PEG ratio of 2.78 and a beta of 0.76.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period last year, the firm posted $0.77 EPS. As a group, research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s payout ratio is currently 28.42%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on DHR shares. Royal Bank Of Canada upped their price target on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. TD Cowen lifted their price objective on Danaher from $236.00 to $255.00 and gave the stock a “buy” rating in a research note on Tuesday. The Goldman Sachs Group lifted their price objective on Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. Wells Fargo & Company cut their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Finally, Morgan Stanley boosted their price objective on Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a research report on Monday. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $235.41.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.